SALTONASE
LIVE

Serial Number

79359491

Owner

BLIRT S.A.

Attorney

Stephen T. Olson

Filing Date

Oct 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SALTONASE Trademark

Serial Number: 79359491

SALTONASE is a trademark filed by BLIRT S.A. on October 25, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

BLIRT S.A.

ul. Trzy Lipy 3/1 38

Entity Type: 16

Trademark Details

Filing Date

October 25, 2022

Registration Date

Not Registered

Goods & Services

Enzymes derived from biotechnological processes for use in industry; enzymes, other than for medical use, for use in the continuous homogenous isothermal amplifications of specific DNA templates for scientific and research purposes; industrial chemicals; chemicals e.g. reagents, materials, manufacturing process components for use in separation other than medical or veterinary purposes including biotechnological, biochemical, chemical and pharmaceutical catalysts; catalysts for chemical and biochemical processes; enzymes for use as biochemical catalysts for industrial purposes; chemicals used in industry, science and photography, agriculture, horticulture and forestry, namely, chemicals, e.g. reagents, materials, manufacturing process components for the separation and purification of mixtures, and for the isolation of substances; chemical products, namely proteins for use in chromatographic processes, other than for medical purposes; chromatographic chemical materials, namely proteins for the treatment of biopolymers, not for medical treatment; artificial porous unprocessed resins for chromatographic purposes; all the aforesaid goods also provided as part of kits.

Chemical research; chemical analytical examinations, namely executing of chemical analysis, quality control, composition control; chemical analysis; biochemical analysis; laboratory analysis in the field of chemistry; analysis of product development, namely product development consultation, composition confirmations, nucleic acid purification efficacy monitoring, chemical, biotechnological, pharmaceutical manufacturing feasibility testing; biotechnological scientific research relating to enzymatic synthesis; scientific research relating to biotechnology; chemical research; chemical technological research; research and development of biotechnology in the field of chemistry, synthetic biology, biotechnology, pharmacy, diagnostics, food processing; chemical analysis services for use in design; chemical analysis services for use in the testing of material.

Ferments for pharmaceutical purposes; enzymes for medical purposes

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2024 OPNR
FINAL REFUSAL WRITTEN
Mar 16, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 18, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 31, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 31, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 11, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 10, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 9, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 10, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 5, 2023 REPR